Jason M. Long, MD
Video-assisted thoracoscopic surgery (VATS) accounts for 40% to 50% of minimally invasive surgical approaches in non–small cell lung cancer (NSCLC), says Jason M. Long, MD. And while robotic resections account for just 14% of all minimally invasive approaches, he anticipates that, “We are going to see an increase in robotic and a decrease in open approaches.”
In an interview during the 2018 OncLive® State of the Science SummitTM on Advanced Non–Small Cell Lung Cancer, Long, assistant professor of surgery, Division of Cardiothoracic Surgery, University of North Carolina at Chapel Hill, discussed the latest developments with minimally invasive surgical approaches in the treatment of patients with NSCLC.
OncLive: How has the use of VATS and robotic surgery impacted the surgical landscape in NSCLC?
Long: Generally, VATS is the minimally invasive approach in lung cancer. However, there is a high and steep learning curve. Unless you undergo that training in fellowship, it’s very hard to convert from an open approach to a VATS approach in practice.
... to read the full story